Chemung Canal Trust’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Chemung Canal Trust's IBB Position: Q1 2022 in Review
Chemung Canal Trust sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,468 shares — an estimated $224K sold.
Chemung Canal Trust first reported a position in IBB in Q2 2016 and held it in 21 quarters. The position peaked at $5.93M in Q1 2017. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.
- Chemung Canal Trust reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
- Chemung Canal Trust sold 1,468 iShares Biotechnology ETF shares in Q1 2022, an estimated $224K.
- Chemung Canal Trust first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 21 quarters.
- Chemung Canal Trust's iShares Biotechnology ETF position peaked at $5.93M in Q1 2017.
- 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.
Based on Chemung Canal Trust's 13F filing for Q1 2022, filed 14 Apr 2022.